Royal Bank of Canada’s Gyre Therapeutics GYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45K | Buy |
6,262
+5,870
| +1,497% | +$42.2K | ﹤0.01% | 5597 |
|
|
2025
Q1 | $3K | Sell |
392
-418
| -52% | -$3.2K | ﹤0.01% | 6099 |
|
|
2024
Q4 | $10K | Sell |
810
-154
| -16% | -$1.9K | ﹤0.01% | 5850 |
|
|
2024
Q3 | $12K | Sell |
964
-88
| -8% | -$1.1K | ﹤0.01% | 5812 |
|
|
2024
Q2 | $13K | Buy |
+1,052
| New | +$13K | ﹤0.01% | 5849 |
|
|
2023
Q4 | – | Sell |
-253
| Closed | – | – | 6718 |
|
|
2023
Q3 | $0 | Buy |
+253
| New | – | ﹤0.01% | 6733 |
|
|
2023
Q2 | – | Sell |
-10
| Closed | – | – | 6899 |
|
|
2023
Q1 | $0 | Buy |
10
+6
| +150% | – | ﹤0.01% | 6761 |
|
|
2022
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 6897 |
|
|
2021
Q3 | – | Sell |
-2,174
| Closed | -$9K | – | 7150 |
|
|
2021
Q2 | $9K | Sell |
2,174
-728
| -25% | -$3.01K | ﹤0.01% | 6403 |
|
|
2021
Q1 | $15K | Buy |
2,902
+968
| +50% | +$5K | ﹤0.01% | 6095 |
|
|
2020
Q4 | $12K | Buy |
1,934
+1,920
| +13,714% | +$11.9K | ﹤0.01% | 5741 |
|
|
2020
Q3 | $0 | Buy |
+14
| New | – | ﹤0.01% | 6200 |
|
|
2020
Q1 | – | Sell |
-3
| Closed | – | – | 6205 |
|
|
2019
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 6252 |
|
|
2018
Q4 | – | Sell |
-229
| Closed | -$2K | – | 5927 |
|
|
2018
Q3 | $2K | Buy |
229
+228
| +22,800% | +$1.99K | ﹤0.01% | 5897 |
|
|
2018
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5979 |
|
|
2017
Q2 | – | Sell |
-11
| Closed | – | – | 5844 |
|
|
2017
Q1 | $0 | Sell |
11
-161
| -94% | – | ﹤0.01% | 5928 |
|
|
2016
Q4 | $0 | Sell |
172
-2
| -1% | – | ﹤0.01% | 5875 |
|
|
2016
Q3 | $0 | Hold |
174
| – | – | ﹤0.01% | 5649 |
|
|
2016
Q2 | $0 | Buy |
+174
| New | – | ﹤0.01% | 5659 |
|
|
2015
Q4 | – | Sell |
-7,699
| Closed | -$36K | – | 5910 |
|
|
2015
Q3 | $36K | Buy |
7,699
+7,502
| +3,808% | +$35.1K | ﹤0.01% | 4719 |
|
|
2015
Q2 | $1K | Buy |
+197
| New | +$1K | ﹤0.01% | 5943 |
|